KOPKOVÁ, Alena, Jiří ŠÁNA, Pavel FADRUS and Ondřej SLABÝ. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. Clinical Chemistry and Laboratory medicine. BERLIN: WALTER DE GRUYTER & CO, 2018, vol. 56, No 6, p. 869-879. ISSN 1434-6621. Available from: https://dx.doi.org/10.1515/cclm-2017-0958.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors
Authors KOPKOVÁ, Alena (203 Czech Republic, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Pavel FADRUS (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Clinical Chemistry and Laboratory medicine, BERLIN, WALTER DE GRUYTER & CO, 2018, 1434-6621.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 20602 Medical laboratory technology ;
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.638
RIV identification code RIV/00216224:14740/18:00105814
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1515/cclm-2017-0958
UT WoS 000431126000012
Keywords in English biomarker; brain cancer; cerebrospinal fluid (CSF); diagnosis; microRNA; prognosis
Tags 14110224, 14110811, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 13/3/2019 13:04.
Abstract
Cerebrospinal fluid (CSF) is a body fluid that has many important functions and is in direct contact with the extracellular environment of the central nervous system (CNS). CSF serves as both the communication channel allowing the distribution of various substances among the CNS cells and the storage facility for the waste products these cells release. For these reasons, CSF is a potential source of diagnostic biomarkers of many CNS diseases, including brain tumors. Recent studies have revealed that CSF also contains circulating microRNAs (miRNAs), short non-coding RNAs that have been described as biomarkers in many cancers. However, CSF miRNAs are difficult to detect, which is why researchers face major challenges, including technological difficulties in its detection and its lack of standardization. Therefore, this review aims (i) to highlight the potential of CSF miRNAs as diagnostic, prognostic and predictive biomarkers in brain tumors, and (ii) to summarize technological approaches for detection of CSF miRNAs.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-33158A, research and development projectName: Nová úroveň molekulární taxonomie glioblastomu založená na expresních profilech dlouhých nekódujících RNA: implikace pro diagnostiku a terapii
NV15-34553A, research and development projectName: Využití mikroRNA v mozkomíšním moku pro diagnostiku mozkových nádorů
PrintDisplayed: 2/5/2024 13:16